Radiopharmaceuticals in PET Imaging Market Size, Share and Forecast 2025 to 2034

Report Id: 2972 Pages: 180 Last Updated: 31 December 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Radiopharmaceuticals in PET Imaging Market-

Radiopharmaceuticals in PET Imaging Market By Radioisotope Type-

  • F-18
    • F-18 FDG
    • F-18 Fiorbetapir
    • F-18 Fiobetaben
    • F-18 Sodium Fluoride
    • Others
  • Rb-82
  • G-68
  • Other PET Isotopes

Radiopharmaceuticals in PET Imaging Market

Radiopharmaceuticals in PET Imaging Market By Application-

  • Oncology
    • Lung Cancer
    • Breast Cancer
    • Others
  • Cardiology
  • Neurology
    • Dementia
    • Parkinson's Disease
    • Others
  • Others

Radiopharmaceuticals in PET Imaging Market By End-User-

  • Hospitals and Clinics
  • Medical Imaging Centers
  • Other End-users

Radiopharmaceuticals in PET Imaging Market By Region-

North America-
• The US
• Canada

Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific

Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Radiopharmaceuticals in PET Imaging Market Snapshot

Chapter 4. Global Radiopharmaceuticals in PET Imaging Market Variables, Trends & Scope

4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.9. Use/impact of AI on Radiopharmaceuticals in PET Imaging Market Industry Trends
4.10. Global Radiopharmaceuticals in PET Imaging Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034

Chapter 5. Radiopharmaceuticals in PET Imaging Market Segmentation 1: By Radioisotope Type, Estimates & Trend Analysis

5.1. Market Share by Radioisotope Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Radioisotope Type:

5.2.1. F-18

5.2.1.1. F-18 FDG
5.2.1.2. F-18 Fiorbetapir
5.2.1.3. F-18 Fiobetaben
5.2.1.4. F-18 Sodium Fluoride
5.2.1.5. Others

5.2.2. Rb-82
5.2.3. G-68
5.2.4. Other PET Isotopes

Chapter 6. Radiopharmaceuticals in PET Imaging Market Segmentation 2: By Application, Estimates & Trend Analysis

6.1. Market Share by Application, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:

6.2.1. Oncology

6.2.1.1. Lung Cancer
6.2.1.2. Breast Cancer
6.2.1.3. Others

6.2.2. Cardiology
6.2.3. Neurology

6.2.3.1. Dementia
6.2.3.2. Parkinson's Disease
6.2.3.3. Others

6.2.4. Others

Chapter 7. Radiopharmaceuticals in PET Imaging Market Segmentation 3: By End User, Estimates & Trend Analysis

7.1. Market Share by End User, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:

7.2.1. Hospitals and Clinics
7.2.2. Medical Imaging Centers
7.2.3. Other End Users

Chapter 8. Radiopharmaceuticals in PET Imaging Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. Global Radiopharmaceuticals in PET Imaging Market, Regional Snapshot 2024 & 2034
8.2. North America

8.2.1. North America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

8.2.1.1. US
8.2.1.2. Canada

8.2.2. North America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope Type, 2021-2034
8.2.3. North America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.4. North America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034

8.3. Europe

8.3.1. Europe Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe

8.3.2. Europe Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope Type, 2021-2034
8.3.3. Europe Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.3.4. Europe Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034

8.4. Asia Pacific

8.4.1. Asia Pacific Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Southeast Asia
8.4.1.7. Rest of Asia Pacific

8.4.2. Asia Pacific Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope Type, 2021-2034
8.4.3. Asia Pacific Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.4. Asia Pacific Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034

8.5. Latin America

8.5.1. Latin America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America

8.5.2. Latin America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope Type, 2021-2034
8.5.3. Latin America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.4. Latin America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034

8.6. Middle East & Africa

8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

8.6.1.1. GCC Countries
8.6.1.2. South Africa
8.6.1.3. Rest of Middle East and Africa

8.6.2. Middle East & Africa Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope Type, 2021-2034
8.6.3. Middle East & Africa Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.6.4. Middle East & Africa Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles

9.2.1. Curium
9.2.2. Telix Pharmaceuticals
9.2.3. Lantheus Holdings, Inc.
9.2.4. GE Healthcare
9.2.5. Life Molecular Imaging
9.2.6. Siemens Healthineers
9.2.7. Avid Radiopharmaceuticals
9.2.8. Cardinal Health
9.2.9. Eckert & Ziegler

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
3454
Security Code field cannot be blank!

Frequently Asked Questions

Radiopharmaceuticals in PET Imaging Market Size is predicted to grow with a 7.1% CAGR during the forecast period for 2025-2034.

Siemens Healthineers AG, GE Healthcare, Eli Lilly and Company, Telix Pharmaceuticals, Bracco Imaging S.p.A., SOFIE Biosciences, Lantheus Holdings, Inc

Radiopharmaceuticals in PET Imaging market is segmented based on Radioisotope Type, Application, and End-user.

North America region is leading the Radiopharmaceuticals in PET Imaging market.

Radiopharmaceuticals in PET Imaging Market Size is valued at USD 1.56 Bn in 2024 and is predicted to reach USD 3.02 Bn by the year 2034

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying